Two Sigma Investments’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-37,012
Closed -$681K – 5639
2026
Q2
$681K Buy
+37,012
New +$560K ﹤0.01% 3912
2025
Q3
– Sell
-8,482
Closed -$275K – 3951
2025
Q2
$275K Buy
8,482
+2,332
+38% +$20.6K ﹤0.01% 2822
2025
Q1
$88.2K Sell
6,150
-2,003
-25% -$48.1K ﹤0.01% 2979
2024
Q4
$181K Buy
8,153
+1,296
+19% +$21.5K ﹤0.01% 2890
2024
Q3
$96K Buy
+6,857
New +$125K ﹤0.01% 2904
2023
Q3
– Sell
-1,405
Closed -$86.8K – 3238
2023
Q2
$86.8K Buy
1,405
+349
+33% +$31.9K ﹤0.01% 2771
2023
Q1
$114K Sell
1,056
-1,664
-61% -$184K ﹤0.01% 2656
2022
Q4
$362K Buy
2,720
+1,990
+273% +$197K ﹤0.01% 2168
2022
Q3
$58K Buy
+730
New +$71.8K ﹤0.01% 2302

Other funds holding VOR

Two Sigma Investments's VOR Position: Q3 2026 in Review

Two Sigma Investments sold out of Vor Biopharma (VOR) in Q3 2026, closing a stake of 37,012 shares — an estimated $681K sold.

Two Sigma Investments first reported a position in VOR in Q3 2022 and held it in 9 quarters. The position peaked at $681K in Q2 2026. 151 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Two Sigma Investments reported no remaining Vor Biopharma position as of Q3 2026 after selling out during the quarter.
  • Two Sigma Investments sold 37,012 Vor Biopharma shares in Q3 2026, an estimated $681K.
  • Two Sigma Investments first reported a position in Vor Biopharma in Q3 2022 and held it in 9 quarters.
  • Two Sigma Investments's Vor Biopharma position peaked at $681K in Q2 2026.
  • 151 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.